Innoviva (INVA) FCF Payout Ratio (QoQ) (2014 - 2022)
Innoviva (INVA) FCF Payout Ratio (QoQ) (2014 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 199.72% |
| Jun 30, 2022 | 82.13% |
| Sep 30, 2021 | -26.70% |
| Jun 30, 2021 | -5.85% |
| Mar 31, 2021 | 759.15% |
| Jun 30, 2020 | -29.23% |
| Mar 31, 2020 | 236.55% |
| Dec 31, 2019 | -185.81% |
| Sep 30, 2019 | 94,223.74% |
| Dec 31, 2018 | 50.05% |
| Sep 30, 2018 | 111.55% |
| Jun 30, 2018 | 767.42% |
| Mar 31, 2018 | -36.08% |
| Dec 31, 2017 | -15.98% |
| Sep 30, 2017 | 213.43% |
| Jun 30, 2017 | -222.62% |
| Mar 31, 2017 | -21.81% |
| Dec 31, 2016 | 18.40% |
| Sep 30, 2016 | -73.82% |
| Jun 30, 2016 | -89.96% |